{
    "id": "34f9bf77-6d88-5782-e063-6294a90a6c54",
    "indications": "tryngolza indicated adjunct diet reduce triglycerides adults familial chylomicronemia syndrome ( fcs ) .",
    "contraindications": "recommended tryngolza 80 mg administered subcutaneously monthly . ( 2.1 ) administer tryngolza abdomen front thigh . back upper arm also used injection site healthcare provider caregiver administers injection . ( 2.2 )",
    "warningsAndPrecautions": "tryngolza injection sterile , preservative-free , clear , colorless yellow solution supplied single-dose autoinjector . autoinjector tryngolza filled deliver 0.8 ml solution containing 80 mg olezarsen . tryngolza available cartons containing one 80 mg single-dose autoinjector ( ndc 71860-101-01 ) .",
    "adverseReactions": "tryngolza contraindicated patients history serious hypersensitivity olezarsen excipients tryngolza . hypersensitivity , including symptoms bronchospasm , diffuse erythema , facial swelling , urticaria , chills , myalgias , requiring medical treatment occurred [ ( 5.1 ) ] .",
    "ingredients": [
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",
            "code": "22ADO53M6F"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM",
            "code": "3980JIH2SW"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "OLEZARSEN SODIUM",
            "code": "NSY2BY6PSB"
        }
    ],
    "organization": "Ionis Pharmaceuticals, Inc.",
    "name": "TRYNGOLZA",
    "effectiveTime": "20250131",
    "indications_original": "TRYNGOLZA is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS).",
    "contraindications_original": "The recommended dosage of TRYNGOLZA is 80 mg administeredÂ subcutaneously once monthly. ( 2.1 ) Administer TRYNGOLZA into the abdomen or front of the thigh. The back of the upper arm can also be used as an injection site if a healthcare provider or caregiver administers the injection. ( 2.2 )",
    "warningsAndPrecautions_original": "TRYNGOLZA injection is a sterile, preservative-free, clear, colorless to yellow solution supplied in a single-dose autoinjector. Each autoinjector of TRYNGOLZA is filled to deliver 0.8 mL of solution containing 80 mg of olezarsen.\n                        TRYNGOLZA is available in cartons containing one 80 mg single-dose autoinjector each (NDC 71860-101-01).",
    "adverseReactions_original": "TRYNGOLZA is contraindicated in patients with a history of serious hypersensitivity to olezarsen or any of the excipients in TRYNGOLZA. Hypersensitivity reactions, including symptoms of bronchospasm, diffuse erythema, facial swelling, urticaria, chills, and myalgias, requiring medical treatment have occurred\n \n  [see\n  \n   Warnings and Precautions (5.1)]\n \n  ."
}